Posts with tag Rare Diseases

Sort by Latest
Italy: Pharmaceutical company fined by the Italian Competition Authority for the sale of a lifesaving drug at excessive prices
Essetifin S.p.A., Leadiant Biosciences Ltd., Leadiant GmbH and Sigma – Tau Arzenmittel GmbH (“Leadiant”) were recently sanctioned by the Italian Competition Authority (“ICA”) after investigations revealed an abuse of dominant position in the national market of the sale and production of a pharmaceutical product made of chenodeoxycholic acid (“CDCA”). CDCA is an active ingredient widely used to cure cerebrotendinous xanthomatosis (“CTX”), an ultra-rare disease. According to the ICA,...
July 18, 2022
6 min read
Cookie consent
We use analytics cookies to help us understand if our website is working well and to learn what content is most useful to visitors. We also use some cookies which are essential to make our website work. You can accept or reject our analytic cookies (including the collection of associated data) and change your mind at any time. Find out more in our Cookie Notice.